US2007037222A1PendingUtilityA1

Lineage restricted glial precursors

Individually held — no corporate assignee on recordPriority: Jul 4, 1997Filed: Jul 14, 2006Published: Feb 15, 2007
Est. expiryJul 4, 2017(expired)· nominal 20-yr term from priority
A61P 25/00C12N 5/0623C12N 2501/395C12N 2506/02G01N 33/5058C12N 2501/135C12N 2510/00A61P 25/28C12N 2503/02C12N 5/0622A61K 35/12
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Glial precursor cell populations from mammalian central nervous system and embryonic stem cells has been isolated. These A2B5 + E-NCAM − glial-restricted precursor (GRP) cells are capable of differentiating into oligodendrocytes, A2B5 + process-bearing astrocytes, and A2B5 − fibroblast-like astrocytes, but not into neurons. GRP cells can be maintained by regeneration in culture. GRP cells differ from oligodendrocyte-type-2 astrocyte (0-2A) progenitor cells in growth factor requirements, morphology, and progeny. Methods of use of GRP cells are also disclosed.

Claims

exact text as granted — not AI-modified
1 . An isolated population of mammalian glial-restricted precursor cells derived from mammalian embryonic stem cells, said mammalian glial-restricted precursor cells being immunonegative for PDGF-α receptor, PDGF-β receptor, and Ran-2 antigen, not labeled with R24 anti-GD3 antibody, and immunopositive for A2B5 antigen.  
     
     
         2 . A method for isolating a population of mammalian glial-restricted precursor cells comprising: 
 (a) incubating mammalian embryonic stem cells under differentiation-inducing conditions so that the cells differentiate; and    (b) isolating a population of mammalian glial-restricted precursor cells by immunoselecting A2B5-immunoreactive cells from the differentiated cells.    
     
     
         3 . The method of  claim 2  wherein immunoselecting A2B5-immunoreactive cells is performed via a procedure selected from the group consisting of specific antibody capture, fluorescence activated cell sorting, and magnetic bead capture.  
     
     
         4 . A population of mammalian CNS glial restricted precursor cells isolated by the method of  claim 2 .  
     
     
         5 . The population of mammalian CNS glial restricted precursor cells of  claim 3  wherein said cells are immunonegative for PDGF-α receptor, PDGF-β receptor, and Ran-2 antigen, not labeled with R24 anti-GD3 antibody, and immunopositive for A2B5 antigen.

Join the waitlist — get patent alerts

Track US2007037222A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.